SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-097496
Filing Date
2011-11-10
Accepted
2011-11-10 15:12:37
Documents
11
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q b87834e10vq.htm 10-Q 388751
2 EX-10.1 b87834exv10w1.htm EX-10.1 11615
3 EX-31.1 b87834exv31w1.htm EX-31.1 5725
4 EX-31.2 b87834exv31w2.htm EX-31.2 6000
5 EX-32.1 b87834exv32w1.htm EX-32.1 3818
  Complete submission text file 0000950123-11-097496.txt   1652463

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT oxgn-20110930.xml EX-101.INS 223217
7 EX-101 SCHEMA DOCUMENT oxgn-20110930.xsd EX-101.SCH 10205
8 EX-101 CALCULATION LINKBASE DOCUMENT oxgn-20110930_cal.xml EX-101.CAL 23909
9 EX-101 LABELS LINKBASE DOCUMENT oxgn-20110930_lab.xml EX-101.LAB 99253
10 EX-101 PRESENTATION LINKBASE DOCUMENT oxgn-20110930_pre.xml EX-101.PRE 62423
11 EX-101 DEFINITION LINKBASE DOCUMENT oxgn-20110930_def.xml EX-101.DEF 12547
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 111194958
SIC: 2836 Biological Products, (No Diagnostic Substances)